| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/05/2015 | WO2015017777A1 Nanochanneled device with electrodes and related methods |
| 02/05/2015 | WO2015017715A1 Drug delivery method |
| 02/05/2015 | WO2015017466A1 Formulation of syk inhibitors |
| 02/05/2015 | WO2015017441A1 Pharmaceutical compositions of ranolazine and dronedarone |
| 02/05/2015 | WO2015017423A2 Stabilized modified release folic acid derivative composition, its therapeutic use and methods of manufacture |
| 02/05/2015 | WO2015016789A1 Powder formulation of valganciclovir |
| 02/05/2015 | WO2015016727A2 Oral dispersible films |
| 02/05/2015 | WO2015016698A1 Pharmaceutical composition with antiinflammatory agents and production process |
| 02/05/2015 | WO2015016697A1 Three-phase system for modified release of a non-steroidal antiinflammatory |
| 02/05/2015 | WO2015016695A1 Novel biphasic-delivery pharmaceutical system for the treatment of pain and inflammation |
| 02/05/2015 | WO2015016694A1 Stable solid immunosuppressor composition |
| 02/05/2015 | WO2015016667A1 Orally disintegrating film preparation containing donepezil or pharmaceutically acceptable salt thereof, and preparation method therefor |
| 02/05/2015 | WO2015016354A1 Liposomes and vaccine composition for inducing cytotoxic t cell activity |
| 02/05/2015 | WO2015016295A1 Pharmaceutical preparation comprising aminopyrazole derivative |
| 02/05/2015 | WO2015016256A1 Tablet |
| 02/05/2015 | WO2015015459A1 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases |
| 02/05/2015 | WO2015015303A2 Instantly wettable oral film dosage form without surfactant or polyalcohol |
| 02/05/2015 | WO2015015254A1 Pharmaceutical compositions of fingolimod |
| 02/05/2015 | WO2015015062A1 Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
| 02/05/2015 | WO2015014987A1 A modified-release oral pharmaceutical formulation containing gliclazide |
| 02/05/2015 | WO2015014980A1 Composition comprising tapentadol in a dissolved form |
| 02/05/2015 | WO2015014965A1 Vesicles |
| 02/05/2015 | WO2015014766A1 Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
| 02/05/2015 | WO2015014737A1 Multilayer tablet formulations comprising tenofovir and entecavir |
| 02/05/2015 | WO2015014730A1 Polysaccharide for use in preventing metastasis formation and/or relapse |
| 02/05/2015 | WO2015014438A1 Stabilised amorphous forms of saxagliptin |
| 02/05/2015 | WO2014127475A9 Therapeutic composition for the treatment perianal disorders |
| 02/05/2015 | US20150038594 Oral dispersible films |
| 02/05/2015 | US20150038572 Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer only throughout a defined administration period commencing shortly before and concluding after radiation therapy |
| 02/05/2015 | US20150038539 Method of increasing the extent of absorption of tizanidine |
| 02/05/2015 | US20150038537 Agents For The Control Of Parasites On Animals |
| 02/05/2015 | US20150038532 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral Administration |
| 02/05/2015 | US20150038504 Formulation of syk inhibitors |
| 02/05/2015 | US20150038491 Solid ivabradine-containing composition |
| 02/05/2015 | US20150038476 Method for Treating Gynecological Diseases |
| 02/05/2015 | US20150038475 Testosterone undecanoate compositions |
| 02/05/2015 | US20150038473 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories |
| 02/05/2015 | US20150038454 Antimicrobial compositions and methods of use |
| 02/05/2015 | US20150038439 Method for preparing suspensions of low-solubility materials |
| 02/05/2015 | US20150038431 Inflammatory eye disorders |
| 02/05/2015 | US20150038428 Organogels and emulsions for biological and non-biological applications |
| 02/05/2015 | US20150038424 Formulations and kits for forming bioadhesive matrices |
| 02/05/2015 | US20150038415 Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent |
| 02/05/2015 | US20150038414 Organic Compounds |
| 02/05/2015 | US20150037442 Composition to Enhance the Bioavailability of Curcumin |
| 02/05/2015 | US20150037438 Chewable gelled emulsions |
| 02/05/2015 | US20150037437 Glioma treatment |
| 02/05/2015 | US20150037429 Controlled Release Microparticles |
| 02/05/2015 | US20150037428 Geometrically engineered particles and methods for modulating macrophage or immune responses |
| 02/05/2015 | US20150037427 Nano delivery systems |
| 02/05/2015 | US20150037425 Powder compositions for inhalation |
| 02/05/2015 | US20150037424 Sustained release oral solid preparation |
| 02/05/2015 | US20150037423 Orally-disintegrating solid preparation |
| 02/05/2015 | US20150037422 Compositions and methods for ocular delivery of a therapeutic agent |
| 02/05/2015 | US20150037421 Arrdc1-mediated microvesicles (armms) and uses thereof |
| 02/05/2015 | US20150037420 Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers |
| 02/05/2015 | US20150037419 Functional PLA-PEG Copolymers, the Nanoparticles Thereof, Their Preparation and Use for Targeted Drug Delivery and Imaging |
| 02/05/2015 | US20150037417 Morphine polymer release system |
| 02/05/2015 | US20150037415 Process for the preparation of a solid, orally administrable pharmaceutical composition |
| 02/05/2015 | US20150037414 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 02/05/2015 | US20150037413 Tamper resistant dosage forms |
| 02/05/2015 | US20150037412 Tamper resistant dosage forms |
| 02/05/2015 | US20150037411 Tamper resistant dosage forms |
| 02/05/2015 | US20150037410 Pharmaceutical compositions of ranolazine and dronedarone |
| 02/05/2015 | US20150037409 Controlled release hydrocodone formulations |
| 02/05/2015 | US20150037408 Delayed Release Pharmaceutical Compositions of Salsalate |
| 02/05/2015 | US20150037407 Method to improve the safety of handling of high potency drugs in solid dosage forms without changing their efficacy |
| 02/05/2015 | US20150037406 Novel crystalline form of sitagliptin sulfate |
| 02/05/2015 | US20150037405 Pharmaceutical compositions of levodopa and carbidopa |
| 02/05/2015 | US20150037404 Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids |
| 02/05/2015 | US20150037402 Methods and Compositions for Treating Gastric Disorders |
| 02/05/2015 | US20150037400 Cytotoxic agents |
| 02/05/2015 | US20150037398 Molecule mixture comprising an amphipathic molecule type a, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type b and a polyphenol c, method for producing said molecule mixture and use thereof |
| 02/05/2015 | US20150037397 Pharmaceutical compositions of pyridinium and quinolinium derivatives |
| 02/05/2015 | US20150037395 Transdermal hormone delivery system: compositions and mtehods |
| 02/05/2015 | US20150037394 Drug delivery formulations |
| 02/05/2015 | US20150037393 Adhesive patches for use in sunless tanning |
| 02/05/2015 | US20150037391 Local administration of gallium compositions to treat pain |
| 02/05/2015 | US20150037390 Self-assembling bis-urea compounds for drug delivery |
| 02/05/2015 | US20150037389 Edible Product Comprising Reconstituted Plant Material |
| 02/05/2015 | US20150037388 Edible slow dissolving film for treating oral ulcerations |
| 02/05/2015 | US20150037386 Compositions and methods for promoting bone formation |
| 02/05/2015 | US20150037382 Microsphere skin treatment |
| 02/05/2015 | US20150037378 Anti-Microbial Formulations Containing Nitric Oxide |
| 02/05/2015 | US20150037372 pH-Responsive High-Density Lipoprotein-Like Particle Complex |
| 02/05/2015 | US20150037368 Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines |
| 02/05/2015 | US20150037348 Human antibodies that bind human il-12 and methods for producing |
| 02/05/2015 | US20150037276 Hydrocolloid composition and an article containing the same |
| 02/05/2015 | US20150037262 Device for the transplantation of cells in suspension |
| 02/05/2015 | US20150035195 Cosmetic textile fiber, method for obtaining it and use thereof |
| 02/04/2015 | EP2832851A1 Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient |
| 02/04/2015 | EP2832723A1 Stabilised amorphous forms of Saxagliptin |
| 02/04/2015 | EP2832373A1 Method to block site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis |
| 02/04/2015 | EP2832372A1 Composition for enteric hard capsule and enteric hard capsule prepared using the composition |
| 02/04/2015 | EP2832371A1 Application of gastrodin as solubilizer and method for preparing injection or powder for injection |
| 02/04/2015 | EP2832370A1 Method for producing drugs and biologically active agents |
| 02/04/2015 | EP2832361A1 Aqueous sustained release compositions of LHRH analogs |
| 02/04/2015 | EP2832359A1 Diquafosol-containing eye drop |
| 02/04/2015 | EP2832353A1 Drug composition, and soft capsule containing same |
| 02/04/2015 | EP2832352A1 Capsule disintegrable in large-intestine-specific manner |